These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1670403)

  • 1. [The treatment of dependence in the therapeutic community].
    Roussaux JP; Ledoux Y; Snoy T; Simonart C; Pelc I
    Acta Psychiatr Belg; 1990; 90(5-6):259-77. PubMed ID: 1670403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of a drug withdrawal unit].
    Stohler R; Petitjean S; Ladewig D
    Ther Umsch; 1993 Mar; 50(3):160-8. PubMed ID: 8386397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The results of drug dependence treatment by therapeutic community in Thanyarak Institute on Drug Abuse.
    Verachai V; Punjawatnun J; Perfas F
    J Med Assoc Thai; 2003 May; 86(5):407-14. PubMed ID: 12859095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of 3-month retention in a drug treatment therapeutic community.
    Mulder RT; Frampton CM; Peka H; Hampton G; Marsters T
    Drug Alcohol Rev; 2009 Jul; 28(4):366-71. PubMed ID: 19594790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
    Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse treatment evolves: a follow-up.
    Spath P
    Hosp Peer Rev; 1997 Sep; 22(9):132-4. PubMed ID: 10173140
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of spirituality and its relevance to addiction treatment.
    Galanter M; Dermatis H; Bunt G; Williams C; Trujillo M; Steinke P
    J Subst Abuse Treat; 2007 Oct; 33(3):257-64. PubMed ID: 17574800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I; Pani PP; Pacini M; Perugi G
    J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mindfulness-based stress reduction in therapeutic community treatment: a stage 1 trial.
    Marcus MT; Schmitz J; Moeller G; Liehr P; Cron SG; Swank P; Bankston S; Carroll DD; Granmayeh LK
    Am J Drug Alcohol Abuse; 2009; 35(2):103-8. PubMed ID: 19322731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the effectiveness of treatment for drug abuse: evidence from the DARP research programme in the United States.
    Sells SB; Simpson DD
    Bull Narc; 1979; 31(1):1-11. PubMed ID: 260891
    [No Abstract]   [Full Text] [Related]  

  • 14. The experience of drug-dependent adolescents in a therapeutic community.
    Foster M; Nathan S; Ferry M
    Drug Alcohol Rev; 2010 Sep; 29(5):531-9. PubMed ID: 20887577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding treatment impact on drug-addicted offenders.
    Brochu S; Cournoyer LG; Tremblay J; Bergeron J; Brunelle N; Landry M
    Subst Use Misuse; 2006; 41(14):1937-49. PubMed ID: 17162598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach.
    Bleich A; Gelkopf M; Weizman T; Adelson M
    Isr J Psychiatry Relat Sci; 2002; 39(2):104-12. PubMed ID: 12227225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Withdrawal treatment of drug dependent patients with the aim of achieving abstinence].
    Stohler R; Petitjean S; Hörler C; Bardeleben U; Ladewig D
    Psychiatr Prax; 1994 Jan; 21(1):10-2. PubMed ID: 8146238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of role models.
    Provet P
    Behav Healthc; 2007 May; 27(5):18-9. PubMed ID: 17958238
    [No Abstract]   [Full Text] [Related]  

  • 20. Remission of psychiatric symptoms among drug misusers after drug dependence treatment.
    Gossop M; Marsden J; Stewart D
    J Nerv Ment Dis; 2006 Nov; 194(11):826-32. PubMed ID: 17102706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.